INGN
Inogen, Inc.
$6.40
-0.01
(-0.16%)
Mkt Cap
173.28M
Volume
215,939
52W Range
5.34-9.13
Sector
Healthcare
Beta
1.65
EPS (TTM)
-0.91
P/E Ratio
-8.03
Revenue (TTM)
351.50M
Rev Growth (5Y)
+2.5%
EPS Growth (5Y)
N/A
Company Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 348.67M | 335.70M | 315.66M | 377.24M | 358.00M | 308.49M | 361.94M | 358.11M | 249.44M | 202.83M | 159.00M | 112.54M |
| Net Income | (22.75M) | (35.89M) | (102.45M) | (83.77M) | (6.33M) | (5.83M) | 20.95M | 51.84M | 21.00M | 20.52M | 11.59M | 6.83M |
| EPS | -0.85 | -1.52 | -4.42 | -3.67 | -0.28 | -0.27 | 0.96 | 2.30 | 1.02 | 1.02 | 0.60 | 0.33 |
| Free Cash Flow | (21.60M) | (11.18M) | (29.75M) | (58.75M) | (302,000) | 19.67M | 34.08M | 47.00M | 50.27M | 23.02M | N/A | N/A |
| FCF / Share | -0.79 | -0.47 | -1.28 | -2.57 | -0.01 | 0.89 | 1.56 | 2.09 | 2.43 | 1.15 | N/A | N/A |
| Operating CF | (11.22M) | 5.91M | (3.23M) | (37.53M) | 23.63M | 37.01M | 40.59M | 59.98M | 60.49M | 31.03M | N/A | N/A |
| Total Assets | 298.62M | 296.19M | 326.19M | 405.04M | 489.51M | 461.85M | 447.34M | 375.90M | 275.07M | 214.05M | N/A | N/A |
| Total Debt | 17.48M | 19.41M | 21.92M | 23.28M | 26.67M | 10.01M | 6.72M | 0 | 0 | 0 | N/A | N/A |
| Cash & Equiv | 103.73M | 113.80M | 125.49M | 187.01M | 235.52M | 211.96M | 198.04M | 196.63M | 142.95M | 92.85M | N/A | N/A |
| Book Value | 192.23M | 173.86M | 204.81M | 297.41M | 370.23M | 349.62M | 344.62M | 310.42M | 227.04M | 182.09M | N/A | N/A |
| Return on Equity | -0.12 | -0.21 | -0.50 | -0.28 | -0.02 | -0.02 | 0.06 | 0.17 | 0.09 | 0.11 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 85.11M | 81.72M | 92.39M | 92.28M | 82.28M | 80.08M | 88.83M | 88.77M | 78.03M | 75.90M | 83.97M | 83.64M |
| Net Income | (8.32M) | (7.13M) | (5.29M) | (4.15M) | (6.17M) | (9.76M) | (5.96M) | (5.59M) | (14.58M) | (26.55M) | (45.72M) | (9.83M) |
| EPS | -0.30 | -0.26 | -0.20 | -0.15 | -0.25 | -0.41 | -0.25 | -0.24 | -0.62 | -1.14 | -1.97 | -0.42 |
| Free Cash Flow | (7.47M) | (3.31M) | 64,000 | 480,000 | (18.83M) | (6.16M) | 2.14M | 1.72M | (8.88M) | (9.45M) | (3.10M) | (4.58M) |
| FCF / Share | -0.27 | -0.12 | 0.00 | 0.02 | -0.75 | -0.26 | 0.09 | 0.07 | -0.38 | -0.41 | -0.13 | -0.20 |
| Operating CF | (6.68M) | (943,000) | 2.17M | 4.35M | (16.79M) | (3.02M) | 6.99M | 6.69M | (4.75M) | (3.15M) | 2.19M | 4.03M |
| Total Assets | 285.93M | 298.62M | 307.01M | 312.04M | 308.41M | 296.19M | 306.17M | 308.92M | 315.60M | 326.19M | 343.70M | 374.35M |
| Total Debt | 16.93M | 17.48M | 18.22M | 19.04M | 19.21M | 19.41M | 20.15M | 21.44M | 22.11M | 21.92M | 22.77M | 21.88M |
| Cash & Equiv | 94.41M | 103.73M | 107.76M | 103.69M | 118.89M | 113.80M | 105.69M | 97.92M | 107.44M | 125.49M | 124.61M | 167.69M |
| Book Value | 182.91M | 192.23M | 197.18M | 199.49M | 197.95M | 173.86M | 185.40M | 187.59M | 191.90M | 204.81M | 230.63M | 274.78M |
| Return on Equity | -0.05 | -0.04 | -0.03 | -0.02 | -0.03 | -0.06 | -0.03 | -0.03 | -0.08 | -0.13 | -0.20 | -0.04 |
INGN News
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript
INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves
Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates
Inogen Announces First Quarter 2026 Financial Results
Inogen (NASDAQ:INGN) Stock Price Passes Above 50 Day Moving Average – Here’s What Happened
Inogen to Report First Quarter 2026 Financial Results on May 7, 2026
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?
Inogen Announces the Appointment of Vafa Jamali to Board of Directors